Clinical trials
4 active studies led by MarsiBionics, of 14 in all
Source: ClinicalTrials.gov, Studies with MarsiBionics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 4Markets in public records
- 0Regions & countries
- 4Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by MarsiBionics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on MarsiBionics
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies MarsiBionics leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with MarsiBionics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show MarsiBionics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets MarsiBionics is in.
From our blog
Stories on the topics MarsiBionics works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Vitamin D: Deficiency, Testing and Supplements
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read